Financials Nova Cannabis Inc.

Equities

NOVC

CA66980W1041

Drug Retailers

Market Closed - Toronto S.E. 17:16:38 27/06/2024 BST 5-day change 1st Jan Change
1.24 CAD +5.98% Intraday chart for Nova Cannabis Inc. 0.00% +39.33%

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 160.4 70.87 50.91 72.64 - -
Enterprise Value (EV) 1 160.4 70.87 50.91 72.64 72.64 72.64
P/E ratio -7.21 x - - - - -
Yield - - - - - -
Capitalization / Revenue - 0.31 x 0.2 x 0.26 x 0.23 x 0.2 x
EV / Revenue - 0.31 x 0.2 x 0.26 x 0.23 x 0.2 x
EV / EBITDA - 11.1 x 2.33 x 3.26 x 2.23 x -
EV / FCF - -8.36 x - 16.9 x 7.31 x -
FCF Yield - -12% - 5.92% 13.7% -
Price to Book - - - - - -
Nbr of stocks (in thousands) 57,093 57,155 57,206 62,082 - -
Reference price 2 2.810 1.240 0.8900 1.240 1.240 1.240
Announcement Date 21/03/22 29/03/23 26/03/24 - - -
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 63.31 - 226.4 259.3 277.2 322 370
EBITDA 1 - - 6.412 21.83 22.26 32.56 -
EBIT 1 - - -7.542 - 12.7 22 -
Operating Margin - - -3.33% - 4.58% 6.83% -
Earnings before Tax (EBT) - - - - - - -
Net income -2.073 -20.61 - - - - -
Net margin -3.27% - - - - - -
EPS - -0.3900 - - - - -
Free Cash Flow 1 - - -8.473 - 4.3 9.934 -
FCF margin - - -3.74% - 1.55% 3.09% -
FCF Conversion (EBITDA) - - - - 19.32% 30.51% -
FCF Conversion (Net income) - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 13/04/21 21/03/22 29/03/23 26/03/24 - - -
1CAD in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 47.6 49.83 56.3 58.91 61.38 - 67.4 64.26 67.8 70.75 74.37 72.8 79.6
EBITDA 1 0.012 -0.174 2.104 2.279 2.203 - 6.391 4.481 5.066 5.918 6.781 - -
EBIT - - - - - - - - - - - - -
Operating Margin - - - - - - - - - - - - -
Earnings before Tax (EBT) - - - - - - - - - - - - -
Net income - - -1.37 - - 2.097 - - - - - - -
Net margin - - -2.43% - - - - - - - - - -
EPS 2 - - -0.0200 - - 0.0400 - - 0.0200 0.0300 0.0400 - -
Dividend per Share - - - - - - - - - - - - -
Announcement Date 21/03/22 09/05/22 12/08/22 08/11/22 29/03/23 08/11/23 26/03/24 08/05/24 - - - - -
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow 1 - - -8.47 - 4.3 9.93 -
ROE (net income / shareholders' equity) - - - - - - -
ROA (Net income/ Total Assets) - - - - - - -
Assets - - - - - - -
Book Value Per Share - - - - - - -
Cash Flow per Share - - - - - - -
Capex 1 - - 8.41 - 5.9 7.2 -
Capex / Sales - - 3.71% - 2.13% 2.24% -
Announcement Date 13/04/21 21/03/22 29/03/23 26/03/24 - - -
1CAD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.24 CAD
Average target price
3.625 CAD
Spread / Average Target
+192.34%
Consensus
  1. Stock Market
  2. Equities
  3. NOVC Stock
  4. Financials Nova Cannabis Inc.